Ioana Maria Andrioaie

Ms. Ioana Maria Andrioaie

Microbiology, Grigore T. Popa University of Medicine and Pharmacy, Iaşi, Romania

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
IAIoana Maria Andrioaie
Ioana Maria Andrioaie
ADAlexandru Duhaniuc
Alexandru Duhaniuc
ENEduard Nastase
Eduard Nastase
LILuminita Smaranda Iancu
Luminita Smaranda Iancu
CLCatalina Lunca
Catalina Lunca
ODOlivia Simona Dorneanu
Olivia Simona Dorneanu
The role of the gut microbiome in mental health has been of great interest in the past years, with several breakthroughs happening in the last decade. Its implications in several psychiatric disorders, namely anxiety, depression, autism and schizophrenia, are highlighted. In this review were included relevant studies on rodents, as well as human studies. There seems to be a connection between the gut microbiome and these pathologies, the link being emphasized both in rodents and humans. The results obtained in murine models align with the results acquired from patients; however, fewer studies regarding anxiety were conducted on humans. The process of sequencing and analyzing the microbiome has been conducted in humans for several other pathologies mentioned above. Additionally, the possible beneficial role of probiotics and postbiotics administered as an aid to the psychiatric medication was analyzed.

24 November 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
FTFelicia Trofin
Felicia Trofin
ODOlivia Simona Dorneanu
Olivia Simona Dorneanu
DCDaniela Constantinescu
Daniela Constantinescu
ENEduard Nastase
Eduard Nastase
CLCatalina Lunca
Catalina Lunca
PCPetru Cianga
Petru Cianga
Introduction: The COVID-19 disease and anti-SARS-CoV-2 vaccination were accompanied by alterations in several inflammatory markers. The aim of our research was to check to what extent such cytokines are transferred to infants via the breastmilk of SARS-CoV-2-infected or vaccinated mothers. Thus, we wanted to check if breastfeeding is safe during SARS-CoV-2 infection or after COVID-19 mRNA-vaccination. Material and method: The Luminex Multiplexing Assay was used for quantifying 10 cytokine in the human breastmilk of SARS-CoV-2-infected or COVID-19-vaccinated mothers, compared with anti-SARS-CoV-2 IgG naïve mothers. Two milk samples were collected at 30 and 60 days either after the booster dose or afterthe onset of symptoms. A single milk sample was collected from the mothers within the control group. Results: The cytokine concentrations were mostly found within the reference intervals for all mothers. The status of the vaccinated/infected mother, the age of the breastfed child, the parity of the mother and the maternal age were variation factors of the above-mentioned cytokine concentrations. The type of birth and the presence of IgG in the milk had no influence on these cytokine concentrations in milk. Furthermore, no statistically significant differences were recorded between the cytokine concentrations of the two milk samples. Conclusion: Our study provides data that support the safety of breastfeeding in the case of mild COVID-19 infection or after Pfizer or Moderna vaccinations.